Uptake of Infliximab Biosimilars Among the Medicare Population.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32702080.
- Also identified by DOI 10.1001/jamainternmed.2020.3188 and PMC identifier 7372498.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cross-sectional study uses Medicare data to examine the uptake of Inflectra and Renflexis, and investigates physician prescribing behavior in switching between biologic and biosimilar versions.
Medical subject headings
- Biosimilar Pharmaceuticals
- Gastrointestinal Agents
- Infliximab
- Practice Patterns, Physicians'